Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600276 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 38.45
- Day Range
- CNY 38.10–40.30
- 52-Week Range
- CNY 35.51–49.74
- Bid/Ask
- CNY 40.03 / CNY 40.04
- Market Cap
- CNY 255.35 Bil
- Volume/Avg
- 49.4 Mil / 26.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 52.90
- Price/Sales
- 10.43
- Dividend Yield (Trailing)
- 0.42%
- Dividend Yield (Forward)
- —
- Total Yield
- 0.42%
Company Profile
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 19,611
- Website
- http://www.hrs.com.cn
Comparables
Valuation
|
Metric
|
600276
|
600594
|
603139
|
|---|---|---|---|
Price/Earnings (Normalized) | 52.90 | — | — |
Price/Book Value | 5.86 | 0.85 | 1.28 |
Price/Sales | 10.43 | 0.88 | 1.84 |
Price/Cash Flow | 28.01 | 5.75 | — |
Price/Earnings
600276
600594
603139
Financial Strength
|
Metric
|
600276
|
600594
|
603139
|
|---|---|---|---|
Quick Ratio | 8.01 | 1.25 | 0.58 |
Current Ratio | 9.12 | 1.90 | 1.05 |
Interest Coverage | — | 1.12 | −1.59 |
Quick Ratio
600276
600594
603139
Profitability
|
Metric
|
600276
|
600594
|
603139
|
|---|---|---|---|
Return on Assets (Normalized) | 10.04% | −0.73% | −1.99% |
Return on Equity (Normalized) | 10.92% | −1.16% | −4.21% |
Return on Invested Capital (Normalized) | 9.87% | −0.40% | −1.20% |
Return on Assets
600276
600594
603139
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Wxkyxvkp | Khs | $823.5 Bil | |||
| Johnson & Johnson
JNJ
| Knsdzcbp | Xmgk | $352.5 Bil | |||
| Merck & Co Inc
MRK
| Rytslzmh | Hfll | $320.3 Bil | |||
| AbbVie Inc
ABBV
| Xtyrmmzs | Jbpq | $295.3 Bil | |||
| AstraZeneca PLC ADR
AZN
| Jbpvsstssm | Fsh | $239.2 Bil | |||
| Novartis AG ADR
NVS
| Kzjydnnb | Mny | $218.9 Bil | |||
| Roche Holding AG ADR
RHHBY
| Mhsnqtnf | Lvtg | $218.6 Bil | |||
| Amgen Inc
AMGN
| Nzlztgrj | Mbpw | $166.8 Bil | |||
| Pfizer Inc
PFE
| Hcgnthf | Pnnpz | $158.9 Bil | |||
| Sanofi SA ADR
SNY
| Bxjbtvnw | Hlwcz | $122.8 Bil |